Brief: Antengene Corp Says FY Revenue RMB160.1 Mln

Antengene

28/03/2023 11:23

March 28 (Reuters) - Antengene Corporation Ltd
 6996.HK :
    * FY REVENUE RMB160.1 MILLION VERSUS RMB28.8 MILLION
    * FY LOSS RMB601.5 MILLION VERSUS LOSS OF RMB655.5 MILLION
    * LOOKING INTO 2023, FURTHER EXPECT TO RECEIVE APPROVALS FOR
SELINEXOR (ATG-010) IN HONG KONG AND MACAU
    * ALSO PLAN TO SUBMIT AN NDA FOR XPOVIO IN INDONESIA IN
FIRST HALF
OF 2023
    * WILL ADVANCE AT LEAST ONE OF OUR PRE-CLINICAL NOVEL ASSETS
INTO
IND STAGE IN 2023

Source text for Eikon:  ID:nHKS7N8VYj 
Further company coverage:  6996.HK